Get started
Author

Antonia Wiala

Observed names: A. Wiala, Wiala Antonia
ORCID: 0000-0003-1029-2302
Observed ORCID: 0000-0003-1029-2302
OpenAlex ID: A5026955703
Anti‐BP180 autoantibody levels at diagnosis correlate with 1‐year mortality rates in patients with bullous pemphigoid
2020 · B. Monshi, L. Gulz, et al. · Journal of the European Academy of Dermatology and Venereology · 25
Automated classification of hidradenitis suppurativa disease severity by convolutional neural network analyses using calibrated clinical images
2023 · A. Wiala, R. Ranjan, et al. · Journal of the European Academy of Dermatology and Venereology · 19
PDF
Patients with PSOriasis and Suppurative Hidradenitis (PSO-SH) share genetic risk factors and are at risk of increased morbidity
2025 · Antonia Wiala, Kareem G. Elhage, et al. · Journal of the American Academy of Dermatology · 11
Addiction and chronic skin diseases: A Pan‐European study on prevalence, associations and patient impact
2025 · Stefanie Ziehfreund, Magdalena Saak, et al. · Journal of the European Academy of Dermatology and Venereology · 7
Oral fusidic acid for the treatment of mild‐to‐moderate hidradenitis suppurativa
2024 · Antonia Wiala, Sophie M. Daschl, et al. · International Journal of Dermatology · 5
Dermatomyositis requires long‐term treatment with combined immunosuppressive and immunoglobulin therapy
2021 · Antonia Wiala, Igor Vujic, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 5
PDF
541 Digital assessment of hidradenitis suppurativa disease activity
2018 · A. Wiala, M. Schöllhammer, et al. · Journal of Investigative Dermatology · 2
PDF
091 Automated classification of hidradenitis suppurativa severity by convolutional neural network analyses using clinical images
2022 · A. Wiala, R. Ranjan, et al. · Journal of Investigative Dermatology · 1
PDF
Hidradenitis suppurativa
2022 · Antonia Wiala, Theresa Stockinger, et al. · ästhetische dermatologie & kosmetologie · 1
Hidradenitis suppurativa
2022 · Antonia Wiala, Theresa Stockinger, et al. · hautnah · 1
051 Differences in the response of dermatologic symptoms and muscular strength after intravenous immunoglobulin therapy in dermatomyositis patients
2017 · A. Wiala, I. Vujic, et al. · Journal of Investigative Dermatology · 1
PDF
Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning
2024 · Wilson Liao, Sugandh Kumar, et al. · Research Square
PDF
The role of histopathology in a case of adult‐onset linear cutaneous lupus
2023 · Wiala Antonia, Rappersberger Klemens, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft
Die Rolle der Histopathologie in einem Fall von linearem kutanem Lupus im Erwachsenenalter
2023 · Antonia Wiala, Klemens Rappersberger, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft
133 Oral fusidic acid for the treatment of mild to moderate hidradenitis suppurativa
2022 · A. Wiala, S. Daschl, et al. · Journal of Investigative Dermatology
PDF
ESDR091 - Automated classification of hidradenitis suppurativa severity by convolutional neural network analyses using clinical images
2022 · Antonia Wiala, Rahul Ranjan, et al.
ESDR133 - Oral fusidic acid for the treatment of mild to moderate hidradenitis suppurativa
2022 · Antonia Wiala, Sophie-Marie Daschl, et al.
Dermatomyositis erfordert eine kombinierte Langzeittherapie mit Immunsuppressiva und intravenösen Immunglobulinen
2021 · Antonia Wiala, Igor Vujic, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft
460 Investigation of senescence-escape reveals new melanoma vulnerabilities
2019 · K. Platzer, A. Wiala, et al. · Journal of Investigative Dermatology
1004 Evaluation of genetic variants in hidradenitis suppurativa patients by exome sequencing
2018 · C. Posch, R. Ahn, et al. · Journal of Investigative Dermatology
Works count: 22
Citation count: 78
H-index: 5
I10-index: 3
Year
Topic
Type